These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38019314)

  • 1. [Consequences of a pandemic for people living with rare diseases and recommendations for maintaining healthcare and participation].
    Zybarth D; Brandt M; Mundlos C; Inhestern L
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2024 Jan; 67(1):57-65. PubMed ID: 38019314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the COVID-19 pandemic on health care and daily life of patients with rare diseases from the perspective of patient organizations - a qualitative interview study.
    Zybarth D; Brandt M; Mundlos C; Inhestern L
    Orphanet J Rare Dis; 2023 Jun; 18(1):154. PubMed ID: 37344904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The psychosocial situation of families caring for children with rare diseases during the COVID-19 pandemic: results of a cross-sectional online survey.
    Rihm L; Dreier M; Rezvani F; Wiegand-Grefe S; Dirmaier J
    Orphanet J Rare Dis; 2022 Dec; 17(1):449. PubMed ID: 36572906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic and rare disease patients' access to healthcare services during a health crisis: The example of the COVID-19 pandemic in Turkey.
    Aktas P
    Health Expect; 2021 Oct; 24(5):1812-1820. PubMed ID: 34309998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A thematic study: impact of COVID-19 pandemic on rare disease organisations and patients across ten jurisdictions in the Asia Pacific region.
    Chung CCY; Ng YNC; Jain R; Chung BHY
    Orphanet J Rare Dis; 2021 Mar; 16(1):119. PubMed ID: 33673852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Healthcare for people with rare diseases: recommendations for successful intersectoral collaboration].
    Inhestern L; Brandt M; Otto R; Zybarth D; Härter M; Bergelt C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Aug; 66(8):940-948. PubMed ID: 37311814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions to support the resilience and mental health of frontline health and social care professionals during and after a disease outbreak, epidemic or pandemic: a mixed methods systematic review.
    Pollock A; Campbell P; Cheyne J; Cowie J; Davis B; McCallum J; McGill K; Elders A; Hagen S; McClurg D; Torrens C; Maxwell M
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013779. PubMed ID: 33150970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of a future scenario concerning the use of big data applications to improve the care of people with rare diseases].
    Sedlmayr B; Knapp A; Kümmel M; Bathelt F; Sedlmayr M
    Z Evid Fortbild Qual Gesundhwes; 2020 Dec; 158-159():81-91. PubMed ID: 33250393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interface management concepts in healthcare for rare diseases in Germany: a study protocol for a mixed-methods study to develop best practice recommendations.
    Inhestern L; Zybarth D; Otto R; Brandt M; Härter M; Bergelt C
    BMJ Open; 2020 Nov; 10(11):e040470. PubMed ID: 33257484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the relationship of COVID-19 related stress and media consumption with schizotypy, depression, and anxiety in cross-sectional surveys repeated throughout the pandemic in Germany and the UK.
    Daimer S; Mihatsch LL; Neufeld SAS; Murray GK; Knolle F
    Elife; 2022 Jul; 11():. PubMed ID: 35781372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19's impact on care practice for alpha-1-antitrypsin deficiency patients.
    Calle Rubio M; López-Campos JL; Miravitlles M; Michel de la Rosa FJ; Hernández Pérez JM; Montero Martínez C; Montoro Ronsano JB; Casas Maldonado F; Rodríguez Hermosa JL; Tabernero Huguet EM; Martínez Sesmero JM; Martínez Rivera C; Callejas González FJ; Torres Durán M
    BMC Health Serv Res; 2023 Jan; 23(1):98. PubMed ID: 36717880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interdisciplinary care path and potential IT support for people with rare diseases in Germany].
    Zoch M; Sedlmayr B; Knapp A; Bathelt F; Helfer S; Schmitt J; Sedlmayr M
    Z Evid Fortbild Qual Gesundhwes; 2021 Oct; 165():68-76. PubMed ID: 34483074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shaping the Future of Rare Diseases after a Global Health Emergency: Organisational Points to Consider.
    Talarico R; Marinello D; Cannizzo S; Gaglioti A; Ticciati S; Carta C; Kodra Y; Azadegan M; Taruscio D; Mosca M; Turchetti G
    Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33238523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social and psychological impact of the COVID-19 pandemic on people with Parkinson's disease: a scoping review.
    Brooks SK; Weston D; Greenberg N
    Public Health; 2021 Oct; 199():77-86. PubMed ID: 34571441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The situation of informal caregivers of working age in the COVID-19 pandemic-results of an online survey in Germany].
    Wiegelmann H; Hess M; Domhoff D; Heinze F; Schmidt A; Seibert K; Stolle C; Preuß B; Rothgang H; Wolf-Ostermann K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Mar; 66(3):265-274. PubMed ID: 36749365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Care for patients with rare diseases].
    Smetsers SE; Takkenberg JJ; Bierings MB
    Ned Tijdschr Geneeskd; 2014; 158():A7960. PubMed ID: 25336312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a national strategy with recommendations for the care of seriously ill and dying people and their relatives in pandemics: A modified Delphi study.
    Gauder S; Pralong A; Rémi C; Hodiamont F; Klinger I; Heckel M; Simon ST; Bausewein C
    Palliat Med; 2022 Sep; 36(8):1285-1295. PubMed ID: 36062725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quantitative and qualitative analysis of patient group narratives suggests common biopsychosocial red flags of undiagnosed rare disease.
    Al-Attar M; Butterworth S; McKay L
    Orphanet J Rare Dis; 2024 Apr; 19(1):172. PubMed ID: 38641814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.